11.08USD+1.09%Mkt Cap: 7.51M USDP/E: —Last update: 2026-05-26
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The compa…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
54.95BSEKP/E 101.9
53.92BSEKP/E 22.9
52.13BDKKP/E 22.1
50.54BUSDP/E 47.4
39.31BEURP/E 18.6
Indicators:|
Key Statistics
Company
Market Cap7.51M USD
Enterprise Value-17.05M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-19.47M USD
Revenue/Share—
Last Price11.08 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees33
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.16
PEG—
EV/EBITDA0.86
EV/Revenue—
P/S—
P/B0.30
EPS (TTM)-31.20
EPS (Forward)-1.19
52W Range
8.6701% of range196.70
52W High196.70 USD
52W Low8.670 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-71.77%
ROA-65.87%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.57M USD
CapEx (TTM)5.00K USD
FCF Margin—
FCF Yield-108.95%
Net Debt-24.33M USD
Net Debt/EBITDA1.22
Balance Sheet
Debt/Equity0.03
Current Ratio11.89
Quick Ratio11.63
Book Value/Sh36.20 USD
Cash/Share37.34 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 30, 2020
Splits
Last Split1:35
Split DateJan 20, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.667.67K
Float482.70K
Insiders13.40%
Institutions18.08%
Short Interest
Short Ratio5.5d
Short % Float9.27%
Short % Out.9.21%
Shares Short60.36K
Short (prev mo.)74.71K
Technical
SMA 5010.89 (+1.8%)
SMA 20024.18 (-54.2%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)12.01K
Avg Vol (10d)12.72K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—